{
    "clinical_study": {
        "@rank": "85880", 
        "brief_summary": {
            "textblock": "This study is designed to determine the influence of food on the absorption and relative\n      bioavailability of oral ganciclovir by comparing the absorption of oral ganciclovir in a fed\n      and fasting state at steady state plasma levels."
        }, 
        "brief_title": "A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir", 
        "condition": [
            "Cytomegalovirus Infections", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Cytomegalovirus Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have the following:\n\n          -  Confirmation of HIV infection by HIV antibody testing, p24 antigen, or culture of\n             HIV.\n\n          -  Documented confirmation of present or past CMV infection.\n\n          -  Must understand the nature of the study, agree to tests required in the protocol, and\n             must understand and sign an informed Consent form approved by the appropriate\n             Institutional Review Board and by Syntex.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded:\n\n          -  Uncontrolled diarrhea or clinically significant gastrointestinal symptoms including\n             persistent nausea or abdominal pain.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Antimetabolites. Interferons. Other nucleoside analogs. Zidovudine (AZT). Any\n             investigational drug.\n\n        Patients with the following are excluded:\n\n          -  Any concomitant conditions listed in Exclusion Co-Existing Conditions.\n\n          -  Karnofsky score < 70.\n\n          -  Hypersensitivity to acyclovir.\n\n          -  Displaying signs of dementia or decreased mentation which would interfere with the\n             ability of the subject to follow protocol schedule.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Anti-cytomegalovirus therapy including ganciclovir therapy for treatment of CMV\n             disease.\n\n          -  Excluded within 4 days of study entry:\n\n          -  Antimetabolites.\n\n          -  Interferons.\n\n          -  Other nucleoside analogs.\n\n          -  Zidovudine (AZT)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "20", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002251", 
            "org_study_id": "059A", 
            "secondary_id": "ICM 1775"
        }, 
        "intervention": {
            "intervention_name": "Ganciclovir", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ganciclovir"
        }, 
        "keyword": [
            "AIDS-Related Opportunistic Infections", 
            "Ganciclovir", 
            "Cytomegalovirus Infections", 
            "Acquired Immunodeficiency Syndrome", 
            "Biological Availability"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94114"
                    }, 
                    "name": "Davies Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Georgetown Univ Med Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "reference": {
            "PMID": "8690817", 
            "citation": "Lavelle J, Follansbee S, Trapnell CB, Buhles WC, Griffy KG, Jung D, Dorr A, Connor J. Effect of food on the relative bioavailability of oral ganciclovir. J Clin Pharmacol. 1996 Mar;36(3):238-41."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002251"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 1991"
    }, 
    "geocoordinates": {
        "Davies Med Ctr": "37.775 -122.419", 
        "Georgetown Univ Med Ctr": "38.895 -77.036"
    }
}